These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29766536)

  • 1. Using accelerated drug stability results to inform long-term studies in shelf life determination.
    Faya P; Seaman JW; Stamey JD
    Stat Med; 2018 Jul; 37(17):2599-2615. PubMed ID: 29766536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One- and two-stage Arrhenius models for pharmaceutical shelf life prediction.
    Fan Z; Zhang L
    J Biopharm Stat; 2015; 25(2):307-16. PubMed ID: 25358076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and accurate prediction of degradant formation rates in pharmaceutical formulations using high-performance liquid chromatography-mass spectrometry.
    Darrington RT; Jiao J
    J Pharm Sci; 2004 Apr; 93(4):838-46. PubMed ID: 14999722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian Approach to Kinetic Modeling of Accelerated Stability Studies and Shelf Life Determination.
    Chau J; Altan S; Burggraeve A; Coppenolle H; Kifle YW; Prokopcova H; Van Daele T; Sterckx H
    AAPS PharmSciTech; 2023 Nov; 24(8):250. PubMed ID: 38036798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bayesian approach to Arrhenius prediction of shelf-life.
    Su XY; Li Wan Po A; Yoshioka S
    Pharm Res; 1994 Oct; 11(10):1462-6. PubMed ID: 7855053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple Approach to Calculate Random Effects Model Tolerance Intervals to Set Release and Shelf-Life Specification Limits of Pharmaceutical Products.
    Montes RO; Burdick RK; Leblond DJ
    PDA J Pharm Sci Technol; 2019; 73(1):39-59. PubMed ID: 30361286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical prediction of drug stability based on nonlinear parameter estimation.
    King SY; Kung MS; Fung HL
    J Pharm Sci; 1984 May; 73(5):657-62. PubMed ID: 6737241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage forms.
    Waterman KC; Carella AJ; Gumkowski MJ; Lukulay P; MacDonald BC; Roy MC; Shamblin SL
    Pharm Res; 2007 Apr; 24(4):780-90. PubMed ID: 17372701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian hierarchical modeling of drug stability data.
    Chen J; Zhong J; Nie L
    Stat Med; 2008 Jun; 27(13):2361-80. PubMed ID: 18338325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating Shelf Life Through Tolerance Intervals.
    Schwenke J; Quinlan M; Stroup W; Forenzo P
    AAPS PharmSciTech; 2020 Oct; 21(8):290. PubMed ID: 33079300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Modern Approach to Stability Studies via Bayesian Linear Mixed Models Incorporating Auxiliary Effects.
    Cordero M; Meinfelder F; Eilert T
    J Pharm Sci; 2024 Jul; 113(7):1779-1793. PubMed ID: 38417792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Practical Discussion on Estimating Shelf Life Through Tolerance Intervals.
    Schwenke J; Forenzo P; Stroup W; Quinlan M
    AAPS PharmSciTech; 2021 Nov; 22(8):273. PubMed ID: 34773146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Algorithm for the early prediction of drug stability using bayesian inference and multiple measurements: Application for predicting the stability of silodosin tablets.
    Nakai Y; Noda A; Yamamoto E
    J Pharm Biomed Anal; 2023 Sep; 233():115442. PubMed ID: 37182365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhenius time-scaled least squares: a simple, robust approach to accelerated stability data analysis for bioproducts.
    Rauk AP; Guo K; Hu Y; Cahya S; Weiss WF
    J Pharm Sci; 2014 Aug; 103(8):2278-86. PubMed ID: 24974956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated storage tests on pharmaceutical products: effect of error structure of assay and errors in recorded temperature.
    Davies OL; Budgett DA
    J Pharm Pharmacol; 1980 Mar; 32(3):155-9. PubMed ID: 6103928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined statistical analyses for long-term stability data with multiple storage conditions: a simulation study.
    Almalik O; Nijhuis MB; van den Heuvel ER
    J Biopharm Stat; 2014; 24(3):493-506. PubMed ID: 24697656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance levels for stability pooling test: a simulation study.
    Chen WJ; Tsong Y
    J Biopharm Stat; 2003 Aug; 13(3):355-74. PubMed ID: 12921387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Shelf-life estimation of pharmaceutical products by matrixing].
    Yoshioka S; Aso Y; Kojima S
    Eisei Shikenjo Hokoku; 1996; (114):143-4. PubMed ID: 9037887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. United States Food and Drug Administration and Department of Defense shelf-life extension program of pharmaceutical products: progress and promise.
    Khan SR; Kona R; Faustino PJ; Gupta A; Taylor JS; Porter DA; Khan M
    J Pharm Sci; 2014 May; 103(5):1331-6. PubMed ID: 24623105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalence tests for shelf life and average drug content in stability studies.
    Djira GD; Hothorn LA; Tsong Y
    J Biopharm Stat; 2008; 18(5):985-95. PubMed ID: 18781530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.